ng28ÄϹ¬ºÍ²³½¡½ñÈÕÐû²¼£¬Öйú¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾Ö½«ÉúÎïÖÆÆ·ÉÏÊÐÉêÇëÂØ¿¨Ä¹£¨lecanemab£¬Ó¢ÎÄÉÌÆ·Ãû£ºLEQEMBI?£©ÄÉÈëÓÅÏÈÉóÆÀ£¬ÕâÊÇÒ»ÖÖ¿¹µí·ÛÑùÂÑ°× (A¦Â) ÔÏËά¿¹Ìå¡£¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾Ö½«Æô¶¯ÓÅÏÈÉóÆÀºÍÅú×¼³ÌÐò£¬Ö¼ÔÚ¼ÓËÙ¾ßÓÐÖØ´óÁÙ´²¼ÛÖµµÄÐÂÒ©µÄÑз¢ºÍÉÏÊС£Æ¾¾Ý¸Ã³ÌÐò£¬Ô¤¼Æ½«Ëõ¶ÌÉóÆÀʱ¼ä¡£
ÔÚÖйú£¬ng28ÄϹ¬ÓÚ2022Äê12ÔÂÏò¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾ÖÌá½»ÉÏÊÐÉêÇë²¢½«Æ¾¾Ý¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾ÖÒªÇóÔö²¹Ïà¹ØÊý¾Ý¡£
ÂØ¿¨Ä¹Ñ¡ÔñÐԵؽáºÏ²¢Çå³ý¿ÉÈܵġ¢¾ßÓÐÉñ¾¶¾ÐÔµÄA¦Â¾Û¼¯Ì壨ÔÏËά£©¡£Òò´Ë£¬ÂØ¿¨Ä¹½«»á¶ÔADµÄ²¡ÀíÉúÀíѧ±¬·¢Ó°Ï죬²¢¼õ»º¼²²¡µÄ½øÕ¹¡£Clarity ADÑо¿ÏÔʾ£¬ÂØ¿¨Ä¹µÄÖÎÁƵִïÁËÖ÷ÒªÖÕµãºÍËùÓÐÒªº¦µÄ´ÎÒªÖյ㣬½á¹û¾ßÓÐÏÔÖøͳ¼ÆѧÒâÒå¡£2022Äê11Ô£¬Clarity AD Ñо¿µÄ½á¹ûÔÚ2022Äê°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©¼¯»áÉÏÐû²¼£¬²¢Í¬Ê±Ðû²¼ÔÚÊÀ½çÖøÃûµÄͬÐÐÆÀÉóҽѧÔÓÖ¾¡¶ÐÂÓ¢¸ñÀ¼Ò½Ñ§ÔÓÖ¾¡·ÉÏ¡£
ÔÚÃÀ¹ú£¬ÂØ¿¨Ä¹ÓÚ2023Äê1ÔÂ6ÈÕ»ñµÃÃÀ¹úʳƷºÍÒ©ÎïÖÎÀí¾Ö£¨FDA£©¼ÓËÙÅú×¼¡£ng28ÄϹ¬ÔÚͬһÌìÌá½»ÁËÒ»·ÝÔö²¹ÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루sBLA£©£¬ÒÔÖ§³ÖתΪ¹Å°åÅú×¼¡£ÔÚÅ·ÖÞ£¬2023Äê1ÔÂ9ÈÕÏòÅ·ÖÞÒ©Æ·ÖÎÀí¾Ö£¨EMA£©Ìá½»ÁËÂØ¿¨Ä¹µÄÉÏÊÐÐí¿ÉÉêÇ루MAA£©²¢ÓÚ1ÔÂ26ÈÕ»ñµÃÊÜÀí¡£ÔÚÈÕ±¾£¬ng28ÄϹ¬ÓÚ2023Äê1ÔÂ16ÈÕÏòÒ©Æ·ºÍÒ½ÁÆÆ÷еÖÎÀí¾Ö£¨PMDA£©Ìá½»ÉÏÊÐÐí¿ÉÉêÇ룬²¢ÓÚ2023Äê1ÔÂ26ÈÕ»ñµÃºñÉúÊ¡ÓÅÏÈÉóÆÀ×ʸñ¡£
ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉng28ÄϹ¬Ö÷µ¼£¬¶ø²úÆ·ÔòÓÉng28ÄϹ¬ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹ㣬ÆäÖÐng28ÄϹ¬ÓµÓÐ×îÖÕ¾ö²ßȨ¡£
Eisai Co., Ltd.
Public Relations Department
TEL: +81-(0)3-3817-5120
INVESTOR CONTACT:
Investor Relations Department
TEL: +81-(0)3-3817-5122
Biogen Inc.
Natacha Gassenbach
+ 1-857-777-6573
public.affairs@biogen.com
Mike Hencke
+ 1-781-464-2442
IR@biogen.com